γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition

Heng Xiao; Rongliang Tong; Chaofeng Ding; Zhen Lv; Chengli Du; Chuanhui Peng; Shaobing Cheng; Haiyang Xie; Lin Zhou; Jian Wu; Shusen Zheng

doi:10.18632/oncotarget.2942

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition

Heng Xiao, Rongliang Tong, Chaofeng Ding, Zhen Lv, Chengli Du, Chuanhui Peng, Shaobing Cheng, Haiyang Xie, Lin Zhou, Jian Wu _ and Shusen Zheng

PDF | HTML | How to cite

Oncotarget. 2015; 6:2180-2192. https://doi.org/10.18632/oncotarget.2942

Metrics: PDF 4227 views | HTML 3275 views | ?

Abstract

Heng Xiao1,2,*, Rongliang Tong1,2,*, Chaofeng Ding1,2, Zhen Lv1,2, Chengli Du1,2, Chuanhui Peng1,2, Shaobing Cheng1,2, Haiyang Xie2, Lin Zhou2, Jian Wu1,2 and Shusen Zheng1,2

1 Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

2 Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, China

* These authors contributed equally to this work

Correspondence:

Jian Wu, email:

Shusen Zheng, email:

Keywords: hepatocellular carcinoma (HCC), γ-H2AX, angiogenesis, vascular endothelial growth factor (VEGF), epidermal growth factor receptor(EGFR), hypoxia inducible factor 1α (HIF-1α)

Received: August 23, 2014 Accepted: December 09, 2014 Published: December 10, 2014

Abstract

Hepatocellular carcinoma (HCC) is one of the most deadly cancers. Using mRNA microarray analysis, we found that H2AX decreased under hypoxic conditions. Hypoxia is an important physiological and pathological stress that induces H2AX phosphorylation (γ-H2AX), but the regulatory mechanism of γ-H2AX remains elusive in the progress of HCC. We report here that increased γ-H2AX expression in HCC is associated with tumor size, vascular invasion, TNM stage and reduced survival rate after liver transplantation (LT). γ-H2AX knockdown was able to effectively inhibit VEGF expression in vitro and tumorigenicity and angiogenesis of HCC in vivo. The mechanism of γ-H2AX on the angiogenic activity of HCC might go through EGFR/HIF-1α/VEGF pathways under hypoxic conditions. Combined γ-H2AX, HIF-1α and EGFR has better prognostic value for HCC after LT. This study suggests that γ-H2AX is associated with angiogenesis of HCC and γ-H2AX or a combination of γ-H2AX/EGFR/HIF-1α is a novel marker in the prognosis of HCC after LT and a potential therapeutic target.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 2942

Publication Alerts

Research Papers:

γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition

Abstract